UK-based private equity company Pamplona Capital Management has agreed to acquire Parexel International Corporation by acquiring the entire outstanding shares of the company in an all-cash transaction.

The purchase consideration for the acquisition has been fixed at $88.1 per share, valuing the transaction at $5bn inclusive of net debt.

The target company is a biopharmaceutical firm based in the US and will become a privately held company following the acquisition, which is expected to be completed by this year's fourth quarter.

"Spherix has reached an agreement to acquire a controlling stake in biopharmaceutical company, Hoth Therapeutics."

Spherix has reached an agreement to acquire a controlling stake in biopharmaceutical company, Hoth Therapeutics.

The acquirer company is a scientific research company also based in the US, and the acquisition is expected to increase Spherix’s shareholder value.

Quantum Hi-Tech China Biological has reached an agreement to acquire Shanghai ChemPartner, a contract research organisation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Both companies involved in the acquisition are based in China. The acquisition is expected to be completed by the end of the year.